Affordable Access

[Cost-effectiveness of the addition of acarbose to the treatment of patients with type-2 diabetes in Spain].

Authors
Type
Published Article
Journal
Gaceta sanitaria / S.E.S.P.A.S
Publication Date
Volume
21
Issue
2
Identifiers
PMID: 17419924
Source
Medline
License
Unknown

Abstract

This long-term economic study showed that the addition of acarbose to existing therapy for DM2 was associated with improvements in life expectancy and QALYs in these patients.

Statistics

Seen <100 times